LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...
TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...
CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...
Consider: the sixth-most prescribed Part D drug in 2013 was a close cousin of Nexium, a heartburn drug called omeprazole, given to nearly 6.4 million beneficiaries, noted Dr. Michael Steinman, a ...
Will the FDA ever allow Ranbaxy Laboratories to sell a generic version of the Nexium heartburn pill? The Connecticut attorney general wants to know what is taking the agency so long, because Ranbaxy ...
The FDA approved the first generic version of Nexium — esomeprazole magnesium delayed-release capsules — to treat gastroesophageal reflux disease. Esomeprazole is a proton pump inhibitor that reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results